|This article does not cite any references or sources. (November 2014)|
|Systematic (IUPAC) name|
|(what is this?)|
Vesnarinone (INN) is a cardiotonic agent. A mixed phosphodiesterase 3 inhibitor and ion-channel modifier that has modest, dose-dependent, positive inotropic activity, but minimal negative chronotropic activity. Vesnarinone improves ventricular performance most in patients with the worst degree of heart failure.
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|